Reich, K., Lebwohl, M., Paul, C., Ropke, M., Rosen, M. and Hansen, K. (2018) “Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis”, SKIN The Journal of Cutaneous Medicine, 2(S1), p. S1. doi: 10.25251/skin.2.supp.1.